MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Short Term Loans and Advances History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Short Term Loans and Advances | ₹1,011 Cr | ₹1,093 Cr | ₹657 Cr | ₹804 Cr | ₹276 Cr |
What is the latest Short Term Loans and Advances ratio of MANKIND PHARMA ?
| Year | Short Term Loans and Advances |
|---|---|
| Mar2025 | ₹1,011 Cr |
| Mar2024 | ₹1,093 Cr |
| Mar2023 | ₹657 Cr |
| Mar2022 | ₹804 Cr |
| Mar2021 | ₹276 Cr |
How is Short Term Loans and Advances of MANKIND PHARMA Trending?
| Years | Short Term Loans and Advances | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,011 Cr | -7.56 | |
| Mar2024 | ₹1,093 Cr | 66.51 | |
| Mar2023 | ₹657 Cr | -18.35 | |
| Mar2022 | ₹804 Cr | 191.64 | |
| Mar2021 | ₹276 Cr | - | |
Compare Short Term Loans and Advances of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹92,068.8 Cr | 3.9% | -2.5% | -22.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,131.0 Cr | -0.7% | -0.5% | -3.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,862.0 Cr | 2.8% | 2.2% | 10.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,254.0 Cr | 1.5% | 3.4% | 12.4% | Stock Analytics | |
| CIPLA | ₹121,198.0 Cr | 0.8% | 0.1% | 3.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,083.0 Cr | 0.4% | 3.2% | 0.3% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 3.9% |
-2.5% |
-22.5% |
| SENSEX | 1% |
0.3% |
6.7% |
You may also like the below Video Courses